Tämä asiakirja on ote EUR-Lex-verkkosivustolta
Asiakirja 22020D0070
Decision of the EEA Joint Committee No 53/2018 of 23 March 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/70]
Decision of the EEA Joint Committee No 53/2018 of 23 March 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/70]
Decision of the EEA Joint Committee No 53/2018 of 23 March 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/70]
OJ L 26, 30.1.2020, s. 33—34
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Voimassa
|
30.1.2020 |
EN |
Official Journal of the European Union |
L 26/33 |
DECISION OF THE EEA JOINT COMMITTEE
No 53/2018
of 23 March 2018
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/70]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2017/2326 of 14 December 2017 approving imiprothrin as an existing active substance for use in biocidal products of product-type 18 (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2017/2327 of 14 December 2017 approving 2-methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 6 (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Decision (EU) 2017/2334 of 14 December 2017 postponing the expiry date of approval of creosote for use in biocidal products of product-type 8 (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12zzzzze (Commission Implementing Regulation (EU) 2017/1383) of Chapter XV of Annex II to the EEA Agreement:
|
‘12zzzzzf. |
32017 R 2326: Commission Implementing Regulation (EU) 2017/2326 of 14 December 2017 approving imiprothrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 333, 15.12.2017, p. 22). |
|
12zzzzzg. |
32017 R 2327: Commission Implementing Regulation (EU) 2017/2327 of 14 December 2017 approving 2-methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 6 (OJ L 333, 15.12.2017, p. 25). |
|
12zzzzzh. |
32017 D 2334: Commission Implementing Decision (EU) 2017/2334 of 14 December 2017 postponing the expiry date of approval of creosote for use in biocidal products of product-type 8 (OJ L 333, 15.12.2017, p. 64).’ |
Article 2
The texts of Implementing Regulations (EU) 2017/2326 and (EU) 2017/2327 and of Implementing Decision (EU) 2017/2334 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 24 March 2018, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 23 March 2018.
For the EEA Joint Committee
The President
Claude MAERTEN
(1) OJ L 333, 15.12.2017, p. 22.
(2) OJ L 333, 15.12.2017, p. 25.
(3) OJ L 333, 15.12.2017, p. 64.
(*1) No constitutional requirements indicated.